KRAS and cancer: A synergistic cytotoxic impact induced by the ATO and VC combination indicates that surpassing an oxidative threshold in KRAS-mutant cancer cells affects the redox-sensitive cellular systems including the most vulnerable mitochondrial oxidative phosphorylation system (OXPHOS) complexes.